본문 바로가기
  • Home

Clinical Effectiveness of a Unani Regimen in the Management of Hasāh al-kuliya (Nephrolithiasis): A Case Report

  • CELLMED
  • Abbr : CellMed
  • 2020, 10(3), pp.23-23
  • DOI : 10.5667/CellMed.2020.0023
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : June 27, 2020
  • Accepted : July 17, 2020
  • Published : August 31, 2020

Ifra Abdul Qaiyyum 1 Mohammad Nawab 2

1Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders
2Department of Moalajat, National Research Institute of Unani Medicine for Skin Disorders

Candidate

ABSTRACT

Hasāh al-kuliya (Nephrolithiasis) is a common disease with a worldwide prevalence of about 12%. A 64 years old male patient, who visited the outpatient department of National Research Institute of Unani Medicine for Skin Disorder (NRIUMSD), Hyderabad, presented with complaints of mild dull pain in right flank region and burning micturition for one month. The ultrasonography of whole abdomen confirmed that there was one stone of 5 mm in calyceal region of each kidney. The patient was treated with the Unani regimen comprising of three formulations Majoon, Hajrul Yahood (5 gm), Jawarish Zarooni Sada (5 gm) and Habb-i-Mudir (1000 mg) for 6 months. The patient did not report any acute pain during the therapy. After 6 months of treatment the ultrasonography of whole abdomen showed absence of the stone from each kidney, ureters and bladder. There was no recurrence of the disease during next 6 months of post treatment follow up. This case report documented the successful medical treatment and prevention of recurrence of bilateral nephrolithiasis through Unani medicines. It concluded that the Unani regimen was effective and safe in the management of bilateral nephrolithiasis.

Citation status

* References for papers published after 2022 are currently being built.